ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaarAalto Pharma AG
Aalto Pharma AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Aalto Pharma AG is a Swiss pharmaceutical company focused on supramolecular API delivery for treating topical infections in humans and animals. The company develops and manufactures supramolecular molecules and a patented delivery platform, which the website describes as non-toxic, non-comedogenic and non-cauterising, and reports bactericidal activity against antibiotic-resistant bacteria such as E. coli, A. baumannii and P. aeruginosa.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
No score yet

Aalto Pharma AG

✓ Offered3
Pharmaceutical Development Areas
Dermatological conditions, fungal nail infections, viral skin and mucous membrane infections, burn wounds and wound care, dental caries and gingivitis.
Supramolecular Drug Delivery Technology
Supramolecular API delivery with an intelligent polymeric carrier for the treatment of topical infections; development and manufacture of solutions for human and veterinary medicine.
Partnering and In-Licensing
Partnering, in-licensing and product co-development for international markets focusing on silver ion based products and multiple therapeutic indications.
Trust & reputation

ranQ Trust Score of Aalto Pharma AG

Trust Score

No score yet

x

A published score requires a data basis of at least 50% and data from at least two criteria groups other than identity. Missing evidence: Review quality, Review volume, Review recency, Media authority

Data basis 54% · As of October 2026

Aalto Pharma AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Aalto Pharma AG scores 67.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.58.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Aalto Pharma AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Aalto Pharma AG scores 0.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.0.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%

The data basis is 54%, below the threshold at which ranQ publishes a score. Evidence is missing for: Review quality, Review volume, Review recency, Media authority. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Aalto Pharma AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Aalto Pharma AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Aalto Pharma AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Aalto Pharma AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Bahnhofstrasse 4
6340 Baar

At a glance

Legal form
Corporation
UID
CHE-374.122.519
Founded
2022 · 4 years
Last commercial register change
April 27, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    OG
    OrchestratePharma GmbH
    Baar
    HS
    HealthWatch Swiss AG
    Baar
    SG
    Stallergenes Greer International AG
    Baar
    TO
    Taiho Oncology Europe GmbH
    Baar
    CA
    Clinuvel AG
    Baar
    RG
    Recipharm Group AG
    Baar
    CR
    Cancer Research and Biotechnology AG
    Baar
    MA
    medmix AG
    Baar